Table of Contents for the Digital Edition of Pharmaceutical Technology - January 2012 Pharmaceutical Technology - January 2012 Table of Contents Here's to a Year of Compromise Cutting Prices to Save Sales All Systems Slow In the Field In the Spotlight Budget Crunch, Politics Shape Policy Agenda Venture-Capital Funding Falls Innovations for 2012 Looking Ahead to an Emerging Class of Biotherapeutic Multilayer-Tablet Technology Broadening the Drug Development and Analytical Toolbox Assessing Tablet-Sticking Propensity Designation of Regulatory Starting Materials in the Manufacturing of Drug Substances: Impact on ANDA Review Time Global Harmonization Opportunities and Challenges Contract Services for 2012 Company Product and Service Profiles Pharma Capsules Industry Pipeline Showcase/Markeplace Innovator Liabillity Still Not Viable after Pliva v. Mensing Ad Index Pharmaceutical Technology - January 2012 Pharmaceutical Technology - January 2012 - Pharmaceutical Technology - January 2012 (Page Cover1) Pharmaceutical Technology - January 2012 - Pharmaceutical Technology - January 2012 (Page Cover2) Pharmaceutical Technology - January 2012 - Pharmaceutical Technology - January 2012 (Page 3) Pharmaceutical Technology - January 2012 - Pharmaceutical Technology - January 2012 (Page 4) Pharmaceutical Technology - January 2012 - Pharmaceutical Technology - January 2012 (Page 5) Pharmaceutical Technology - January 2012 - Pharmaceutical Technology - January 2012 (Page 6) Pharmaceutical Technology - January 2012 - Pharmaceutical Technology - January 2012 (Page 7) Pharmaceutical Technology - January 2012 - Table of Contents (Page 8) Pharmaceutical Technology - January 2012 - Table of Contents (Page 9) Pharmaceutical Technology - January 2012 - Table of Contents (Page 10) Pharmaceutical Technology - January 2012 - Table of Contents (Page 11) Pharmaceutical Technology - January 2012 - Here's to a Year of Compromise (Page 12) Pharmaceutical Technology - January 2012 - Here's to a Year of Compromise (Page 13) Pharmaceutical Technology - January 2012 - Cutting Prices to Save Sales (Page 14) Pharmaceutical Technology - January 2012 - Cutting Prices to Save Sales (Page 15) Pharmaceutical Technology - January 2012 - All Systems Slow (Page 16) Pharmaceutical Technology - January 2012 - All Systems Slow (Page 17) Pharmaceutical Technology - January 2012 - In the Field (Page 18) Pharmaceutical Technology - January 2012 - In the Field (Page 19) Pharmaceutical Technology - January 2012 - In the Field (Page 20) Pharmaceutical Technology - January 2012 - In the Field (Page 21) Pharmaceutical Technology - January 2012 - In the Field (Page 22) Pharmaceutical Technology - January 2012 - In the Field (Page 23) Pharmaceutical Technology - January 2012 - In the Field (Page 24) Pharmaceutical Technology - January 2012 - In the Field (Page 25) Pharmaceutical Technology - January 2012 - In the Spotlight (Page 26) Pharmaceutical Technology - January 2012 - In the Spotlight (Page 27) Pharmaceutical Technology - January 2012 - Budget Crunch, Politics Shape Policy Agenda (Page 28) Pharmaceutical Technology - January 2012 - Budget Crunch, Politics Shape Policy Agenda (Page 29) Pharmaceutical Technology - January 2012 - Budget Crunch, Politics Shape Policy Agenda (Page 30) Pharmaceutical Technology - January 2012 - Budget Crunch, Politics Shape Policy Agenda (Page 31) Pharmaceutical Technology - January 2012 - Budget Crunch, Politics Shape Policy Agenda (Page 32) Pharmaceutical Technology - January 2012 - Budget Crunch, Politics Shape Policy Agenda (Page 33) Pharmaceutical Technology - January 2012 - Budget Crunch, Politics Shape Policy Agenda (Page 34) Pharmaceutical Technology - January 2012 - Budget Crunch, Politics Shape Policy Agenda (Page 35) Pharmaceutical Technology - January 2012 - Venture-Capital Funding Falls (Page 36) Pharmaceutical Technology - January 2012 - Venture-Capital Funding Falls (Page 37) Pharmaceutical Technology - January 2012 - Innovations for 2012 (Page 38) Pharmaceutical Technology - January 2012 - Innovations for 2012 (Page 39) Pharmaceutical Technology - January 2012 - Innovations for 2012 (Page 40) Pharmaceutical Technology - January 2012 - Innovations for 2012 (Page 41) Pharmaceutical Technology - January 2012 - Looking Ahead to an Emerging Class of Biotherapeutic (Page 42) Pharmaceutical Technology - January 2012 - Looking Ahead to an Emerging Class of Biotherapeutic (Page 43) Pharmaceutical Technology - January 2012 - Looking Ahead to an Emerging Class of Biotherapeutic (Page 44) Pharmaceutical Technology - January 2012 - Looking Ahead to an Emerging Class of Biotherapeutic (Page 45) Pharmaceutical Technology - January 2012 - Looking Ahead to an Emerging Class of Biotherapeutic (Page 46) Pharmaceutical Technology - January 2012 - Looking Ahead to an Emerging Class of Biotherapeutic (Page 47) Pharmaceutical Technology - January 2012 - Multilayer-Tablet Technology (Page 48) Pharmaceutical Technology - January 2012 - Multilayer-Tablet Technology (Page 49) Pharmaceutical Technology - January 2012 - Multilayer-Tablet Technology (Page 50) Pharmaceutical Technology - January 2012 - Multilayer-Tablet Technology (Page 51) Pharmaceutical Technology - January 2012 - Broadening the Drug Development and Analytical Toolbox (Page 52) Pharmaceutical Technology - January 2012 - Broadening the Drug Development and Analytical Toolbox (Page 53) Pharmaceutical Technology - January 2012 - Broadening the Drug Development and Analytical Toolbox (Page 54) Pharmaceutical Technology - January 2012 - Broadening the Drug Development and Analytical Toolbox (Page 55) Pharmaceutical Technology - January 2012 - Broadening the Drug Development and Analytical Toolbox (Page 56) Pharmaceutical Technology - January 2012 - Assessing Tablet-Sticking Propensity (Page 57) Pharmaceutical Technology - January 2012 - Assessing Tablet-Sticking Propensity (Page 58) Pharmaceutical Technology - January 2012 - Assessing Tablet-Sticking Propensity (Page 59) Pharmaceutical Technology - January 2012 - Assessing Tablet-Sticking Propensity (Page 60) Pharmaceutical Technology - January 2012 - Assessing Tablet-Sticking Propensity (Page 61) Pharmaceutical Technology - January 2012 - Assessing Tablet-Sticking Propensity (Page 62) Pharmaceutical Technology - January 2012 - Designation of Regulatory Starting Materials in the Manufacturing of Drug Substances: Impact on ANDA Review Time (Page 63) Pharmaceutical Technology - January 2012 - Designation of Regulatory Starting Materials in the Manufacturing of Drug Substances: Impact on ANDA Review Time (Page 64) Pharmaceutical Technology - January 2012 - Designation of Regulatory Starting Materials in the Manufacturing of Drug Substances: Impact on ANDA Review Time (Page 65) Pharmaceutical Technology - January 2012 - Designation of Regulatory Starting Materials in the Manufacturing of Drug Substances: Impact on ANDA Review Time (Page 66) Pharmaceutical Technology - January 2012 - Global Harmonization Opportunities and Challenges (Page 67) Pharmaceutical Technology - January 2012 - Contract Services for 2012 (Page 68) Pharmaceutical Technology - January 2012 - Contract Services for 2012 (Page 69) Pharmaceutical Technology - January 2012 - Contract Services for 2012 (Page 70) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 71) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 72) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 73) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 74) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 75) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 76) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 77) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 78) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 79) Pharmaceutical Technology - January 2012 - Company Product and Service Profiles (Page 80) Pharmaceutical Technology - January 2012 - Pharma Capsules (Page 81) Pharmaceutical Technology - January 2012 - Industry Pipeline (Page 82) Pharmaceutical Technology - January 2012 - Industry Pipeline (Page 83) Pharmaceutical Technology - January 2012 - Industry Pipeline (Page 84) Pharmaceutical Technology - January 2012 - Industry Pipeline (Page 85) Pharmaceutical Technology - January 2012 - Showcase/Markeplace (Page 86) Pharmaceutical Technology - January 2012 - Showcase/Markeplace (Page 87) Pharmaceutical Technology - January 2012 - Innovator Liabillity Still Not Viable after Pliva v. Mensing (Page 88) Pharmaceutical Technology - January 2012 - Innovator Liabillity Still Not Viable after Pliva v. Mensing (Page 89) Pharmaceutical Technology - January 2012 - Ad Index (Page 90) Pharmaceutical Technology - January 2012 - Ad Index (Page Cover3) Pharmaceutical Technology - January 2012 - Ad Index (Page Cover4) http://digital.findpharma.com/nxtbooks/advanstar/pt_201202_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201202 http://digital.findpharma.com/nxtbooks/advanstar/pt_201201 http://digital.findpharma.com/nxtbooks/advanstar/pt_201112 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111 http://digital.findpharma.com/nxtbooks/advanstar/pt_201111_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201110 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109 http://digital.findpharma.com/nxtbooks/advanstar/pt_201109_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201108 http://digital.findpharma.com/nxtbooks/advanstar/pt_201108_supplmnt http://digital.findpharma.com/nxtbooks/advanstar/pt_201107 http://digital.findpharma.com/nxtbooks/advanstar/pt_201106 http://digital.findpharma.com/nxtbooks/advanstar/pt_201105_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201105 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104 http://digital.findpharma.com/nxtbooks/advanstar/pt_201104_supp http://digital.findpharma.com/nxtbooks/advanstar/pt_201103 http://digital.findpharma.com/nxtbooks/advanstar/pt_201102 http://digital.findpharma.com/nxtbooks/advanstar/pt_201101 http://digital.findpharma.com/nxtbooks/advanstar/pt_201012 http://digital.findpharma.com/nxtbooks/advanstar/pt_201011 http://digital.findpharma.com/nxtbooks/advanstar/pt_201010 http://digital.findpharma.com/nxtbooks/advanstar/pt_201009 http://digital.findpharma.com/nxtbooks/advanstar/pt_201008 http://digital.findpharma.com/nxtbooks/advanstar/pt_201007 http://digital.findpharma.com/nxtbooks/advanstar/pt_201006 http://digital.findpharma.com/nxtbooks/advanstar/pt_201005 http://digital.findpharma.com/nxtbooks/advanstar/pt_201004 http://digital.findpharma.com/nxtbooks/advanstar/pt_201003 http://digital.findpharma.com/nxtbooks/advanstar/pt201002 http://digital.findpharma.com/nxtbooks/advanstar/pt_201001 http://digital.findpharma.com/nxtbooks/advanstar/pt_200912 http://digital.findpharma.com/nxtbooks/advanstar/pt_200911 http://digital.findpharma.com/nxtbooks/advanstar/pt10_2009 http://digital.findpharma.com/nxtbooks/advanstar/pt_200909 http://digital.findpharma.com/nxtbooks/advanstar/pt_200908 http://digital.findpharma.com/nxtbooks/advanstar/pt_200907 http://digital.findpharma.com/nxtbooks/advanstar/pt_200906 http://digital.findpharma.com/nxtbooks/advanstar/pt_200905 http://www.nxtbook.com/nxtbooks/advanstar/pt_200904 http://www.nxtbook.com/nxtbooks/advanstar/pt_200903 http://www.nxtbook.com/nxtbooks/advanstar/pt_200902 http://www.nxtbook.com/nxtbooks/advanstar/pt_200901 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.